Holen Sie sich die Stockscreener-App
86.62
0.29%
0.3468
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ALC?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$86.27
Offen:
$87.55
24-Stunden-Volumen:
2.02M
Relative Volume:
1.27
Marktkapitalisierung:
$42.54B
Einnahmen:
$10.19B
Nettoeinkommen (Verlust:
$1.05B
KGV:
41.16
EPS:
2.1044
Netto-Cashflow:
$1.38B
1W Leistung:
+3.96%
1M Leistung:
+7.09%
6M Leistung:
+6.22%
1J Leistung:
-7.28%
1-Tages-Spanne:
$85.92
$87.64
1-Wochen-Bereich:
$82.06
$87.64
52-Wochen-Spanne:
$71.55
$99.20
Alcon Inc Stock (ALC) Company Profile
Compare ALC vs ISRG, BDX, MDLN, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALC
Alcon Inc
|
86.61 | 42.38B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
ISRG
Intuitive Surgical Inc
|
506.90 | 179.76B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
176.89 | 51.48B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
MDLN
Medline Inc
|
49.77 | 39.09B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
RMD
Resmed Inc
|
256.21 | 36.79B | 5.40B | 1.49B | 1.78B | 10.12 |
Alcon Inc Stock (ALC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-30 | Eingeleitet | William Blair | Mkt Perform |
| 2026-01-20 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2026-01-09 | Herabstufung | Stifel | Buy → Hold |
| 2025-12-11 | Herabstufung | BofA Securities | Buy → Underperform |
| 2025-08-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-05-20 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2025-05-14 | Bestätigt | BTIG Research | Buy |
| 2025-03-28 | Bestätigt | Needham | Buy |
| 2025-03-25 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-01-24 | Bestätigt | Needham | Buy |
| 2025-01-10 | Hochstufung | Redburn Atlantic | Neutral → Buy |
| 2024-12-17 | Bestätigt | Needham | Buy |
| 2024-11-12 | Bestätigt | Needham | Buy |
| 2024-10-10 | Hochstufung | Redburn Atlantic | Sell → Neutral |
| 2024-09-10 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-07-15 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2024-05-15 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2024-04-10 | Eingeleitet | Goldman | Buy |
| 2024-03-14 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Overweight |
| 2024-01-23 | Eingeleitet | Bernstein | Outperform |
| 2023-12-18 | Herabstufung | Redburn Atlantic | Neutral → Sell |
| 2023-12-12 | Eingeleitet | Stifel | Buy |
| 2023-12-04 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2023-08-17 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-05-10 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2023-03-01 | Hochstufung | Societe Generale | Sell → Hold |
| 2022-12-22 | Eingeleitet | Mizuho | Buy |
| 2022-11-17 | Herabstufung | Societe Generale | Hold → Sell |
| 2022-08-11 | Herabstufung | Societe Generale | Buy → Hold |
| 2022-05-13 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-05-12 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2022-04-08 | Eingeleitet | Needham | Buy |
| 2022-03-11 | Eingeleitet | BofA Securities | Buy |
| 2022-01-18 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2022-01-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-01 | Eingeleitet | Oppenheimer | Perform |
| 2021-07-14 | Eingeleitet | Deutsche Bank | Buy |
| 2021-05-06 | Hochstufung | Citigroup | Sell → Neutral |
| 2021-03-22 | Hochstufung | BTIG Research | Neutral → Buy |
| 2020-11-12 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-07-06 | Herabstufung | Citigroup | Neutral → Sell |
| 2020-07-06 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-06-16 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-04-08 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-03-26 | Hochstufung | Argus | Hold → Buy |
| 2020-03-24 | Hochstufung | Societe Generale | Sell → Hold |
| 2020-03-13 | Hochstufung | UBS | Neutral → Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Neutral |
| 2020-02-26 | Hochstufung | Berenberg | Hold → Buy |
| 2020-01-08 | Eingeleitet | Argus | Hold |
| 2019-10-29 | Eingeleitet | Stephens | Equal-Weight |
| 2019-08-21 | Bestätigt | BofA/Merrill | Neutral |
| 2019-06-24 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2019-06-14 | Eingeleitet | BTIG Research | Neutral |
| 2019-05-10 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-05-02 | Eingeleitet | Credit Suisse | Outperform |
Alle ansehen
Alcon Inc Aktie (ALC) Neueste Nachrichten
Lensar® provides update on pending acquisition by Alcon - marketscreener.com
LENSAR Updates Timeline for Pending Alcon Acquisition Review - TipRanks
LENSAR-Alcon deal closing pushed to first half of 2026 - Investing.com
ALC.SW Alcon Inc. (SIX) ends CHF64.26 25 Feb 2026: heavy volume, earnings focus - Meyka
Lensar, Alcon still working on US FTC second request, aim to close before July - MLex
LENSAR Provides Update on Alcon Acquisition Status - Intellectia AI
LENSAR-Alcon deal closing pushed to first half of 2026 By Investing.com - Investing.com South Africa
LENSAR® Provides Update on Pending Acquisition by Alcon - The Manila Times
LENSAR Provides Update, Expects Alcon Acquisition to Close in H1 2026 Pending FTC Approval - TradingView
LENSAR, Inc. Provides Update on Acquisition Status by Alcon Research, LLC - Quiver Quantitative
Alcon Posts Strong Q4 2025 Sales Growth and Robust Cash Generation - The Globe and Mail
Tariffs, Competition Ding Alcon’s Future - WFMZ.com
Alcon (SWX:ALC) Margin Decline Tests Bullish Growth Narrative Despite Higher FY 2025 Revenue - simplywall.st
Alcon Inc (ALC) (Full Year 2025) Earnings Call Highlights: Strong Revenue Growth Amid Market ... By GuruFocus - Investing.com Canada
Alcon (ALC) Q4 2025 Earnings Call Transcript - The Globe and Mail
Alcon (ALC) Reports Strong Q4 2025 Performance with 7% Sales Gro - GuruFocus
Alcon targets 5%–7% sales growth in 2026 while expanding Unity platform and launching new IOLs - MSN
Alcon (ALC) Receives New "Buy" Rating and Raised Price Target fr - GuruFocus
Alcon: Markets forgive Q4 miss for a healthy 2026 outlook - marketscreener.com
Alcon Inc (ALC) Stock Price Up 3.55% on Feb 25 - GuruFocus
Alcon's Q4 Earnings Miss Estimates, Stock Falls, Revenues Rise Y/Y - The Globe and Mail
Global Ophthalmic Drugs Market Estimated at US$41.88 Billion in 2026; Projected to Grow at 7.9% CAGR Through 2036 - GlobeNewswire Inc.
Alcon Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Eye-care group Alcon expects product launches to drive 2026 sales, profitability - WKZO
Earnings Flash (ALC.L) Alcon Inc. Reports FY25 Revenue $10.32B - marketscreener.com
Alcon's FY25 Net Income Falls; Sales Up - marketscreener.com
Alcon (ALC) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Alcon (ALC) Reports Q4 Revenue Slightly Below Expectations - GuruFocus
Alcon (ALC) Shares Fall After Q4 2025 Earnings Miss - GuruFocus
Alcon slips as Q4 financial results miss on both lines - MSN
Alcon’s 2025 Annual Report Showcases Innovation-Led Growth and Strategic Eye-Care Expansion - TipRanks
Alcon Q4 Core Earnings, Sales Rise - marketscreener.com
Earnings Flash (ALC) Alcon Posts Q4 Core EPS $0.78, vs. FactSet Est of $0.79 - marketscreener.com
Alcon Delivers Strong Fourth-Quarter 2025 Topline Growth as New Product Launches Accelerate Sales - The AI Journal
Ophthalmic Operating Tables Market Is Going to Boom | Alcon • B. Braun Melsungen AG • Geuder AG - openPR.com
Earnings Preview: Alcon - Benzinga
Alcon AG expected to post earnings of 78 cents a shareEarnings Preview - TradingView
How Alcon Inc. Ordinary Shares stock reacts to weak economyWeekly Trend Recap & Expert Approved Trade Ideas - mfd.ru
Alcon Inc. (ALC.SW, SIX) earnings 24 Feb 2026: watch margins and guidance - Meyka
Gear Up for Alcon (ALC) Q4 Earnings: Wall Street Estimates for Key Metrics - Yahoo Finance
Alcon (ALC) Receives a Buy from RBC Capital - The Globe and Mail
Alcon Targets Underserved Vision Segment With New Multifocal Toric Lens - Yahoo Finance
Assessing Alcon (SWX:ALC) Valuation After Recent Share Price Momentum And Mixed Return Profile - Yahoo Finance
Alcon (ALC) Executive Joins Charles River in Key Legal Role - GuruFocus
Alcon Inc. (ALC): A bull case theory - MSN
Alcon (ALC) Veteran Joins Charles River as Chief Legal Officer - GuruFocus
RBC Updates Alcon Estimates Ahead of FY25 Earnings; Outperform Rating Kept - marketscreener.com
ALC.SW Alcon (SIX) closes CHF61.90 on 17 Feb 2026: earnings may set next trend - Meyka
Here are Updates on Alcon’s (ALC) Compensation and Sustainability Matters - Insider Monkey
Alcon Launches TOTAL30 Multifocal for Astigmatism, the World's O - GuruFocus
Alcon Launches Total30 Multifocal for Astigmatism, the Monthly Multifocal Toric Contact Lens with Water Gradient Technology - marketscreener.com
Finanzdaten der Alcon Inc-Aktie (ALC)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.05%
2.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):